Cytokine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Cytokine Market is segmented by Cytokine Type, Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen. There are two types of cytokines used to treat patients with cancer, namely, interferons (INFs) and interleukins (ILs). A third type, called hematopoietic growth factors, is used to counteract some of the side effects of certain chemotherapy regimens. The growing interest, over the past two decades, in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks, to develop cancer treatments. They directly stimulate immune effector cells and stromal cells at the tumor site and enhance tumor cell recognition by cytotoxic effector cells. Numerous animal tumor model studies have demonstrated that cytokines have broad anti-tumor activity, which has been translated into a number of cytokine-based approaches for cancer therapy. Cytokines have proven to be effective in the treatment of cancer and may continue to play a major role in the development of cancer immunotherapy. Cytokines are finding increasing acceptance in cancer therapy over the world.

Scope of the Report

As per the scope of the report, cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust but self-limited response to a target antigen. The multi-faceted applications of cytokines in various domains, like prophylactic, diagnostic, and therapeutic uses, to cure various diseases, have widened the horizons of the cytokine market, globally. The Cytokine market is segmented by Cytokine Type, Therapeutic Application, and Geography. As per the scope, cytokine antagonists are considered in the studied report.

By Cytokine Type
Tumor Necrosis Factor-TNF
Epidermal Growth Factor-EGF
Other Cytokine Types
By Therapeutic Application
Asthma and Airway Inflammation
Other Therapeutic Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Cancer is Expected to Hold the Largest Share of the Market

The mixture of cytokines that are produced in the cancer microenvironment has an important role in cancer pathogenesis. Cytokines that are released in response to infection, inflammation, and immunity can function to inhibit cancer development and progression. Alternatively, cancer cells can respond to host-derived cytokines that promote growth, attenuate apoptosis, and facilitate invasion and metastasis. To circumvent these impediments, cytokines are have been investigated clinically with new engineered cytokine mutants (superkines), chimeric antibody-cytokine fusion proteins (immunokines), anticancer vaccines, checkpoint inhibitors, and cancer-directed monoclonal antibodies to increase their antibody-dependent cellular cytotoxicity or sustain cellular responses and anticancer efficacy.

Moreover, the demand for this therapy is expected to increase as Cancer Research UK suggests that the population suffering from cancer is expected to increase across the globe in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040, as compared to 17 million in 2018. This factor is, hence, expected to help the market growth.


North American Region Holds the Largest Market Share of the Cytokine Market

North America is dominating the cytokine market, due to the rising prevalence of cancer in the region. Numerous animal tumour model studies have demonstrated that cytokines have broad anti-tumour activity, which has been translated into a number of cytokine-based approaches for cancer therapy. As per the American Cancer Society, there were an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States, numbers which are expected to rise in future. Augmenting growth in the R&D of cancer therapy, along with lesser side effects (as compared to chemotherapy), has predisposed cytokine therapy, which is a non-specific immunotherapy. This factor has increased the market share of cytokines among cancer therapies, in the United States.


Competitive Landscape

The cytokine market consists of several major players. The comapanies are implementing certain strategic initiatives, such as a mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. For instance, in October 2017, US FDA approved Stelara (ustekinumab) for the treatment of adolescents with moderate-to-severe plaque psoriasis, which is developed by Janssen Pharmaceutica.

Recent Developments


Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Acceptance in Cancer Therapy

      2. 4.2.2 Use of Cytokine as a Potential Biomarker for Neonatal Sepsis

      3. 4.2.3 Potential Contribution in Stem Cell Therapy

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs

      2. 4.3.2 Lacks Specificity

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Cytokine Type

      1. 5.1.1 Tumor Necrosis Factor-TNF

      2. 5.1.2 Interleukins-Il

      3. 5.1.3 Interferons-IFN

      4. 5.1.4 Epidermal Growth Factor-EGF

      5. 5.1.5 Other Cytokine Types

    2. 5.2 By Therapeutic Application

      1. 5.2.1 Cancer

      2. 5.2.2 Asthma and Airway Inflammation

      3. 5.2.3 Arthritis

      4. 5.2.4 Other Therapeutic Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 GlaxoSmithkline PLC

      2. 6.1.2 Novartis International AG

      3. 6.1.3 Amgen

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 Sanofi SA

      6. 6.1.6 AstraZeneca plc

      7. 6.1.7 Biocon Limited

      8. 6.1.8 Abbvie Inc

      9. 6.1.9 Johnson and Johnson

      10. 6.1.10 UCB S.A

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cytokine Market market is studied from 2018 - 2026.

The Cytokine Market is growing at a CAGR of 6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Novartis, Pfizer, Sanofi, AbbVie Inc, UCB S.A are the major companies operating in Cytokine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!